| Indivior PLC (INDV) Q1 2025 Earnings Conference Call Transcript |
Indivior PLC (NASDAQ:INDV ) Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ET Company Participants Jason Thompson - Head, IR Mark Crossley - CEO Ryan Preblick - CFO Conference Call Participants Carl Burns - Northland Capital Markets David Amsellem - Piper Sandler Christian Glennie - Stifel Chase Knickerbocker - Craig-Hallum Thibault Boutherin - Morgan Stanley Paul Cuddon - Deutsche Numis Operator Good day and thank you for standing by. Welcome to the Indivior PLC Q1 2025 Financial Results Conference Call. |
seekingalpha.com |
2025-04-24 14:45:16 |
Czytaj oryginał (ang.) |
| Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates |
Indivior PLC (INDV) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.37 per share a year ago. |
zacks.com |
2025-04-24 12:05:36 |
Czytaj oryginał (ang.) |
| Indivior Announces Further Changes to Board of Directors |
RICHMOND, Va. , March 4, 2025 /PRNewswire/ -- Indivior PLC (NASDAQ / LSE: INDV) ("Indivior" or the "Company") today announced that, further to the announcement on December 17, 2024 of certain Director arrangements agreed with Oaktree Capital Management L.P. |
prnewswire.com |
2025-03-04 10:40:00 |
Czytaj oryginał (ang.) |
| UK's Indivior appoints Joe Ciaffoni as CEO |
British drugmaker Indivior on Thursday said it appointed Joe Ciaffoni as its new CEO, replacing current boss Mark Crossley. |
reuters.com |
2025-02-27 04:48:51 |
Czytaj oryginał (ang.) |
| Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer |
RICHMOND, Va. , Feb. 27, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) has appointed Joe Ciaffoni, currently an Independent Non-Executive Director of the Company, as Chief Executive Officer. |
prnewswire.com |
2025-02-27 04:00:00 |
Czytaj oryginał (ang.) |
| Indivior PLC (INDV) Q4 2024 Earnings Call Transcript |
Indivior PLC (INDV) Q4 2024 Earnings Call Transcript |
seekingalpha.com |
2025-02-20 16:26:48 |
Czytaj oryginał (ang.) |
| European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat |
Indivior Plc INDV stock plunged following the company's fiscal year 2025 guidance that fell short of Street expectations. |
benzinga.com |
2025-02-20 16:13:23 |
Czytaj oryginał (ang.) |
| Indivior PLC (INDV) Q4 Earnings Meet Estimates |
Indivior PLC (INDV) came out with quarterly earnings of $0.32 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.43 per share a year ago. |
zacks.com |
2025-02-20 10:05:26 |
Czytaj oryginał (ang.) |
| Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024 |
Data show rapid initiation with once-monthly SUBLOCADE significantly improves retention in opioid use disorder (OUD) patients, especially among fentanyl-positive participants. Study also administered second SUBLOCADE injection a week later vs. standard 28 days, enabling patients to achieve and maintain target medication levels more quickly. |
prnewswire.com |
2024-11-19 14:52:00 |
Czytaj oryginał (ang.) |
| Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior |
RICHMOND, Va. , Nov. 7, 2024 /PRNewswire/ -- Indivior PLC (NASDAQ / LSE: INDV) the Board of Directors (the "Board") of Indivior plc ("Indivior" or the "Company") notes the publication today of a letter from Oaktree Capital Management LP ("Oaktree") to the Board of Indivior. |
prnewswire.com |
2024-11-07 16:24:00 |
Czytaj oryginał (ang.) |
| Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month |
RICHMOND, Va., Oct. 30, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV), in recognizing Substance Abuse Prevention Month, provides an update on key findings from the last year that demonstrate the importance of access to medications for the treatment of opioid use disorder (MOUD) and the effectiveness and safety of SUBLOCADE® in the treatment of OUD. These data add to the growing body of evidence that SUBLOCADE can improve outcomes, such as abstinence, retention, and recovery in persons with OUD. |
prnewswire.com |
2024-10-30 14:30:00 |
Czytaj oryginał (ang.) |
| Indivior PLC (INDV) Q3 2024 Earnings Call Transcript |
Indivior PLC (NASDAQ:INDV ) Q3 2024 Earnings Conference Call October 24, 2024 8:00 AM ET Company Participants Jason Thompson - Head, IR Mark Crossley - CEO Christian Heidbreder - Chief Scientific Officer Ryan Preblick - CFO Conference Call Participants David Amsellem - Piper Sandler Chase Knickerbocker - Craig-Hallum Paul Cudden - Deutsche Numis Christian Glennie - Stifel Operator Good day and thank you for standing by. Welcome to the Indivior PLC Third Quarter 2024 Conference Call. |
seekingalpha.com |
2024-10-24 18:02:09 |
Czytaj oryginał (ang.) |
| Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates |
Indivior PLC (INDV) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.34 per share a year ago. |
zacks.com |
2024-10-24 12:05:16 |
Czytaj oryginał (ang.) |
| Indivior price target slashed after second profit warning of the year |
Indivior PLC (LSE:INDV) received a sharp downgrade from investment bank Stifel, cutting its price target from 2,100p to 1,400p, following the company's second profit warning of 2024. Stifel cites rising competition from rival drug Brixadi as a key reason for lowering estimates and slashing earnings forecasts by more than 20%. |
proactiveinvestors.co.uk |
2024-10-14 13:32:59 |
Czytaj oryginał (ang.) |
| Indivior: This Value Stock Has Over 100% Upside Potential If Market Share Stabilizes In 2025 |
Indivior is a $970m small-cap facing to transitory headwinds resulting in extremely negative sentiment and fascinatingly low valuation. Due to the extreme mis-pricing I argue Indivior offers investors great risk/reward asymmetry with upside potential of 104% based on today's share price of $7.46. Temporary headwinds like Medicaid disenrollments, market share loses affecting Sublocade growth and ongoing antitrust litigations are priced in at a current forward EV/EBITDA of 2.3x. |
seekingalpha.com |
2024-10-13 14:00:00 |
Czytaj oryginał (ang.) |
| Indivior plunges on profit warning as rival anti-opioid product sells faster than expected |
Indivior PLC (LSE:INDV) shares dropped over 16% after the drug company warned that sales of its Sublocade long-lasting opioid addiction treatment were hit by a rise in rival generic versions. Management of the group now sees lower than expected revenue from Sublocade in the third quarter and full year from a combination of faster initial adoption of a competitor's rival long-acting injectable treatment, as well as other factors. |
proactiveinvestors.co.uk |
2024-10-10 12:18:56 |
Czytaj oryginał (ang.) |
| British drugmaker Indivior cuts 2024 revenue forecast, shares fall |
British drugmaker Indivior on Thursday cut its 2024 net revenue forecast for the second time in three months, citing lower than expected revenues from its Sublocade treatment for opioid use disorder, sending shares 15% lower. |
reuters.com |
2024-10-10 11:33:55 |
Czytaj oryginał (ang.) |
| Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights – INDV |
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=106508&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-10-01 20:30:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Indivior PLC(INDV) Shareholders |
NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Indivior investors who were adversely affected by alleged securities fraud between February 22, 2024 and July 8, 2024. |
prnewswire.com |
2024-10-01 19:14:00 |
Czytaj oryginał (ang.) |
| Investors in Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV |
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=106403&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-10-01 15:00:00 |
Czytaj oryginał (ang.) |
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Indivior PLC of Class Action Lawsuit and Upcoming Deadlines - INDV |
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Indivior PLC ("Indivior" or the "Company") (NASDAQ:INDV) and certain officers. The class action, filed in the United States District Court for the Eastern District of Virginia (Richmond Division), and docketed under 24-cv- 00554, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Indivior securities between February 22, 2024 and July 8, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officers. |
accesswire.com |
2024-10-01 14:45:00 |
Czytaj oryginał (ang.) |
| Indivior PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV |
NEW YORK, NY / ACCESSWIRE / October 1, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=106338&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-10-01 11:15:00 |
Czytaj oryginał (ang.) |
| FINAL INDV DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Indivior PLC Investors to Join the Class Action Lawsuit! |
NEW YORK CITY, NY / ACCESSWIRE / October 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Indivior PLC ("Indivior" or "the Company") (NASDAQ:INDV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Indivior securities between February 22, 2024, and July 8, 2024, inclusive (the "Class Period"). |
accesswire.com |
2024-10-01 11:00:00 |
Czytaj oryginał (ang.) |
| Indivior PLC Investors: Please contact the Portnoy Law Firm to recover your losses. October 1, 2024 Deadline to file Lead Plaintiff Motion |
Investors can contact the law firm at no cost to learn more about recovering their losses Investors can contact the law firm at no cost to learn more about recovering their losses |
globenewswire.com |
2024-09-30 23:29:00 |
Czytaj oryginał (ang.) |
| Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior Lawsuit – INDV |
NEW YORK, NY / ACCESSWIRE / September 30, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=106253&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-09-30 20:45:00 |
Czytaj oryginał (ang.) |
| Shareholders that lost money on Indivior PLC(INDV) should contact Levi & Korsinsky about pending Class Action - INDV |
NEW YORK, NY / ACCESSWIRE / September 30, 2024 / If you suffered a loss on your Indivior PLC (NASDAQ:INDV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/indivior-lawsuit-submission-form?prid=106247&wire=1 or contact Joseph E. Levi, Esq. |
accesswire.com |
2024-09-30 20:15:00 |
Czytaj oryginał (ang.) |
| Investors who lost money on Indivior PLC(INDV) should contact Levi & Korsinsky about pending Class Action - INDV |
NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Indivior PLC ("Indivior" or the "Company") (NASDAQ: INDV) of a class action securities lawsuit. |
globenewswire.com |
2024-09-30 17:56:00 |
Czytaj oryginał (ang.) |
| The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Indivior PLC (INDV) |
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 1, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Indivior PLC (“Indivior” or the “Company”) (NASDAQ: INDV) securities between February 22, 2024 and July 8, 2024, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On July 9, 2024, Indivior disclosed that it would be immediately. |
businesswire.com |
2024-09-30 16:00:00 |
Czytaj oryginał (ang.) |